164 related articles for article (PubMed ID: 38021344)
1. Bioinspired and biomimetic cancer-cell-derived membrane nanovesicles for preclinical tumor-targeted nanotheranostics.
Prasad R; Mendes BB; Gorain M; Chandra Kundu G; Gupta N; Peng B; Aung Win EH; Qing H; Conde J
Cell Rep Phys Sci; 2023 Nov; 4(11):101648. PubMed ID: 38021344
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic bright optotheranostics for metastasis monitoring and multimodal image-guided breast cancer therapeutics.
Prasad R; Peng B; Mendes BB; Kilian HI; Gorain M; Zhang H; Kundu GC; Xia J; Lovell JF; Conde J
J Control Release; 2024 Mar; 367():300-315. PubMed ID: 38281670
[TBL] [Abstract][Full Text] [Related]
3. Bioinspired soft nanovesicles for site-selective cancer imaging and targeted therapies.
Prasad R; Conde J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1792. PubMed ID: 35318815
[TBL] [Abstract][Full Text] [Related]
4. Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents.
Bose RJC; Uday Kumar S; Zeng Y; Afjei R; Robinson E; Lau K; Bermudez A; Habte F; Pitteri SJ; Sinclair R; Willmann JK; Massoud TF; Gambhir SS; Paulmurugan R
ACS Nano; 2018 Nov; 12(11):10817-10832. PubMed ID: 30346694
[TBL] [Abstract][Full Text] [Related]
5. Genetically engineered PD-1 displaying nanovesicles for synergistic checkpoint blockades and chemo-metabolic therapy against non-small cell lung cancer.
Li B; Yang T; Liu J; Yu X; Li X; Qin F; Zheng J; Liang J; Zeng Y; Zhou Z; Liu L; Zhang B; Yao W; Feng Z; Zeng G; Zhou Q; Chen L
Acta Biomater; 2023 Apr; 161():184-200. PubMed ID: 36893957
[TBL] [Abstract][Full Text] [Related]
6. Self-recognizing and stimulus-responsive carrier-free metal-coordinated nanotheranostics for magnetic resonance/photoacoustic/fluorescence imaging-guided synergistic photo-chemotherapy.
Tu L; Fan Z; Zhu F; Zhang Q; Zeng S; Chen Z; Ren L; Hou Z; Ye S; Li Y
J Mater Chem B; 2020 Jul; 8(26):5667-5681. PubMed ID: 32500886
[TBL] [Abstract][Full Text] [Related]
7. Biomimetic "Nanoplatelets" as a Targeted Drug Delivery Platform for Breast Cancer Theranostics.
Li L; Fu J; Wang X; Chen Q; Zhang W; Cao Y; Ran H
ACS Appl Mater Interfaces; 2021 Jan; 13(3):3605-3621. PubMed ID: 33449625
[TBL] [Abstract][Full Text] [Related]
8. Cancer Cell Membrane-Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy.
Chen Z; Zhao P; Luo Z; Zheng M; Tian H; Gong P; Gao G; Pan H; Liu L; Ma A; Cui H; Ma Y; Cai L
ACS Nano; 2016 Nov; 10(11):10049-10057. PubMed ID: 27934074
[TBL] [Abstract][Full Text] [Related]
9. Light/pH-Triggered Biomimetic Red Blood Cell Membranes Camouflaged Small Molecular Drug Assemblies for Imaging-Guided Combinational Chemo-Photothermal Therapy.
Ye S; Wang F; Fan Z; Zhu Q; Tian H; Zhang Y; Jiang B; Hou Z; Li Y; Su G
ACS Appl Mater Interfaces; 2019 May; 11(17):15262-15275. PubMed ID: 30964624
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
11. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
[TBL] [Abstract][Full Text] [Related]
12. Microfluidics-Prepared Ultra-small Biomimetic Nanovesicles for Brain Tumor Targeting.
Wang J; Ma X; Wu Z; Cui B; Zou C; Zhang P; Yao S
Adv Healthc Mater; 2024 Feb; 13(5):e2302302. PubMed ID: 38078359
[TBL] [Abstract][Full Text] [Related]
13. Trojan-Horse Diameter-Reducible Nanotheranostics for Macroscopic/Microscopic Imaging-Monitored Chemo-Antiangiogenic Therapy.
Fan Z; Shi D; Zuo W; Feng J; Ge D; Su G; Yang L; Hou Z
ACS Appl Mater Interfaces; 2022 Feb; 14(4):5033-5052. PubMed ID: 35045703
[TBL] [Abstract][Full Text] [Related]
14. Dually targeted bioinspired nanovesicle delays advanced prostate cancer tumour growth in vivo.
Ma G; Severic M; Barker M; Pereira S; Ruiz A; Cheung CCL; Al-Jamal WT
Acta Biomater; 2021 Oct; 134():559-575. PubMed ID: 34274531
[TBL] [Abstract][Full Text] [Related]
15. Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics.
Jin J; Bhujwalla ZM
Front Oncol; 2019; 9():1560. PubMed ID: 32039028
[TBL] [Abstract][Full Text] [Related]
16. Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC.
Chen H; Deng J; Yao X; He Y; Li H; Jian Z; Tang Y; Zhang X; Zhang J; Dai H
J Nanobiotechnology; 2021 Oct; 19(1):342. PubMed ID: 34702291
[TBL] [Abstract][Full Text] [Related]
17. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.
Marshall SK; Angsantikul P; Pang Z; Nasongkla N; Hussen RSD; Thamphiwatana SD
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235009
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable nanotheranostics with hyperthermia-induced bubble ability for ultrasound imaging-guided chemo-photothermal therapy.
Xu C; Gao F; Wu J; Niu S; Li F; Jin L; Shi Q; Du L
Int J Nanomedicine; 2019; 14():7141-7153. PubMed ID: 31564870
[TBL] [Abstract][Full Text] [Related]
19. Genetically Engineered Plasma Membrane Nanovesicles for Cancer-Targeted Nanotheranostics.
Zhang P; Chen H; Liu J; Liu G
Methods Mol Biol; 2019; 2054():283-294. PubMed ID: 31482462
[TBL] [Abstract][Full Text] [Related]
20. Biomimetic dual-responsive bioengineered nanotheranostics for intracellular cascade-synthesizing chemo-drugs and efficient oncotherapy.
Zhang X; Zhu X; He Y; Zhang Y; Huang S; Yi X; Li Y; Hou Z; Fan Z
J Mater Chem B; 2022 Dec; 11(1):119-130. PubMed ID: 36504220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
